Schonfeld Strategic Advisors »

Revolution Medicines shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.6M 35k 46.70
2025-06-30 $479k 13k 36.79
2025-03-31 $696k 20k 35.36
2024-12-31 $875k 20k 43.74
2024-09-30 $337k 7.4k 45.35

More positions owned by Schonfeld Strategic Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Ethereum Tr SHS (ETHA)
Fidelity Wise Origin Bitcoin SHS (FBTC)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ark 21shares Bitcoin Etf Shs Ben Int (ARKB)
Broadcom (AVGO)
Ishares Tr Core S&p500 Etf (IVV)
Alibaba Group Hldg Sponsored Ads (BABA)
Union Pacific Corporation (UNP)
Tesla Motors (TSLA)
Marvell Technology (MRVL)
Boston Scientific Corporation (BSX)

View all positions for Schonfeld Strategic Advisors

Top funds holding Revolution Medicines

Vanguard Group
Farallon Capital Management
Henderson Group
Wellington Management Company
Baker Bros. Advisors
FMR
BlackRock
Nextech Invest
Paradigm Biocapital Advisors
Bellevue Group
State Street Corporation
T. Rowe Price Investment Management
Alphabet
BVF
Deerfield Management Company

View all funds holding Revolution Medicines